External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nauwelaers, Inne, Laudus, Nele, Peeters, Dieter, Acs, Balazs, Denkert, Carsten, Michiels, Stefan, Horlings, Hugo, Siziopikou, Kalliopi P., Ely, Scott, Zardavas, Dimitrios, Mustimbo, Roberts, Bartlett, John, Floris, Giuseppe, Hartman, Johan, van Deurzen, Carolien H. M., Ceusters, Dorien, Dequeker, Els, Salgado, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367276/
https://www.ncbi.nlm.nih.gov/pubmed/35954426
http://dx.doi.org/10.3390/cancers14153762
Descripción
Sumario:New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

Ejemplares similares